Vanderbilt-Ingram Cancer Center is “pushing the envelope” with new technologies like histotripsy and new programs like robotic liver surgery and robotic pancreas surgery, serving patients not only from Tennessee, but also parts of Kentucky, Alabama and Georgia.  

Study findings suggest a new therapeutic approach for a rare digestive disorder, microvillus inclusion disease.

The collaboration will integrate Vanderbilt Health’s Molecular AI Initiative capabilities with Bertis’ deep proteomics and AI-enabled technologies to identify novel therapeutic targets and predictive biomarkers.

Appealing to patients for its noninvasive nature, it avoids many of the traditional drawbacks of surgeries that use incisions, including pain management. 

Since January 2020, members of the VUH CCOT have responded to more than 10,000 rapid response calls in every non-ICU unit in the adult hospital.

The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023. 

Emergency general surgery account for more than 4 million hospital admissions annually, with patients experiencing three times the mortality rate when compared with elective surgical patients.